Bill Snyder

August 23, 2018

Clue to treating obesity found in body’s ‘rheostat’

Researchers at Vanderbilt University and the University of Michigan have discovered a critical factor in the rheostatic control of body weight by the brain.

By Bill Snyder
August 23, 2018

New award honors research by graduate students

The Vanderbilt University School of Medicine has established a new award to recognize and support outstanding graduate students who have distinguished themselves through the excellence, significance and scientific rigor of their work.

By Bill Snyder
August 16, 2018

Predictive models for gene regulation

Using new computational approaches to understand the behavior of cells should aid efforts to predict how mutations affect cell function and how diseases respond to drug combinations.

By Bill Snyder
August 9, 2018

Kropski, Shoemaker honored by Doris Duke Foundation

Two early-career physician-scientists at Vanderbilt University Medical Center are among 18 recipients of 2018 Clinical Scientist Development Awards announced July 31 by the Doris Duke Charitable Foundation.

By Bill Snyder
August 2, 2018

Grant set to boost patient-centered outcomes research

Vanderbilt University Medical Center has been awarded a five-year federal grant to train investigators in Learning Healthcare Systems research, aimed at improving patient outcomes and the community’s overall health.

By Bill Snyder
July 26, 2018

Integrated, multidisciplinary approach key to opioid fight: panel

No single approach will end the epidemic of fatal overdoses caused by addiction to opioid painkillers and heroin that is ravaging this country, the U.S. Assistant Secretary for Health, Adm. Brett Giroir, MD, warned Tuesday during a panel discussion in a packed lecture hall at Vanderbilt University Medical Center.

By Bill Snyder
July 19, 2018

Team finds potent antibodies against three Ebola viruses

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.
By Bill Snyder
July 2, 2018

SMAD4 clue to colon cancer

Loss of a gene that is part of the TGF-beta signaling pathway increased inflammation in the colon and was observed in half of human colitis-associated cancers.
By Bill Snyder
June 29, 2018

Scavengers “protect” HDL

Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease.
By Bill Snyder
June 28, 2018

Ikizler to succeed Harris as Nephrology and Hypertension director

Jun. 28, 2018—T. Alp Ikizler, MD, an internationally known expert on the nutritional and metabolic aspects of kidney disease, will succeed Raymond Harris, MD, as director of the Department of Medicine’s Division of Nephrology and Hypertension in the Vanderbilt University School of Medicine effective July 1.
By Bill Snyder
June 28, 2018

Team identifies new gene candidates for breast cancer risk

Jun. 28, 2018—An international coalition led by scientists at Vanderbilt University Medical Center and the QIMR Berghofer Medical Research Institute in Herston, Australia, has identified 48 candidate susceptibility genes for breast cancer risk, including 14 genes at loci (chromosome regions) not yet reported for breast cancer.
By Bill Snyder
June 21, 2018

Roden’s circulatory diseases research honored

Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.
By Bill Snyder
1 … 57 58 59 60 61 … 115